To be eligible, products must have received marketing aproval in the USA by December 31 of the year preceding the award, but not more than 5 years earlier than December 31 of that year, unless the award is for a new and innovative indication, which must have been added within the previous 5 years.

The pharmaceutical, biotechnology, diagnostics and medical device products considered for the Prix Galien USA Award must be fully FDA approved (provisional approvals are not sufficient).


Award categories:

As many as three awards will be given for each of the following categories:

Jury Submission Criteria

Read the Charter of the Prix Galien USA Committee